Thepatent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, peripheral ...

Potency assays are central to proving a therapy activity and safety, yet for advanced therapies like cell and gene therapies ...

Longeveron receives Japanese patent for potency assay methods to assess human mesenchymal stem cells: Miami Saturday, January 31, 2026, 13:00 Hrs [IST] Longeveron Inc, a clinical ...

Text mining and knowledge graphs connect cell-culture parameters to glycosylation for faster bioprocess optimization.

Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...

Cell and gene therapies (CGTs) are revolutionizing treatment, but increasing regulatory scrutiny has led to a rise in costly ...

Professor Lisa Volpatti developed a targeted approach that directs anti-inflammatory proteins to diseased arteries, reducing ...

WOBURN, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

There are many superfoods on the market today, but few are as nutritious as chlorella. Like spirulina, chlorella is a type of ...

Heavy and long-term use of marijuana has the potential to cause lung cancer. CBDs (cannabinoids) are chemical compounds found ...

Life, Inc., a clinical-stage biotechnology company developing highly selective T cell engagers (TCEs) to treat cancer and autoimmune diseases, today announced the appointment of Dimitrios Chondros, MD ...

Detailed price information for Kyverna Therapeutics Inc (KYTX-Q) from The Globe and Mail including charting and trades.